Feng‐Yuan Liu
Papers
1
Total Citations
16
H-Index
1
About
Feng-Yuan Liu is a leading researcher in oncologic imaging, with a primary focus on prostate cancer diagnostics. His work centers on the comparative evaluation of advanced imaging modalities for detecting biochemical recurrence after radical prostatectomy. In a pivotal 2020 study, Liu and his team systematically compared 68Ga-PSMA-11 PET/CT with multiparametric magnetic resonance imaging in Taiwanese patients who had undergone robot-assisted radical prostatectomy. This research, which has garnered 16 citations, demonstrated the superior sensitivity of PSMA PET/CT in identifying recurrent lesions, particularly at low PSA levels, thereby guiding salvage therapy decisions. Liu’s contributions have helped establish evidence-based imaging protocols for post-surgical surveillance, directly impacting clinical management in Asian populations. His work bridges nuclear medicine and radiology, offering nuanced insights into the complementary roles of these technologies. By addressing diagnostic challenges in biochemically recurrent prostate cancer, Liu has advanced precision oncology and improved outcomes for patients facing disease relapse. His research continues to shape international guidelines and inspire further investigations into hybrid imaging strategies.
Research Focus
Key Achievements
Top Papers
- 1